| For: | Chen XY, Wang C, Huang YZ, Zhang LL. Nonalcoholic fatty liver disease shows significant sex dimorphism. World J Clin Cases 2022; 10(5): 1457-1472 [PMID: 35211584 DOI: 10.12998/wjcc.v10.i5.1457] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i5/1457.htm |
| Number | Citing Articles |
| 1 |
Jiajing Chao, Zhangmin Tan, Yiwen Zhang, Qian Gao, Zhe Li, Chengfang Xu. Identification of Estrogen-Related Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver Disease Through Machine Learning and Single-Cell Analysis. Clinical and Translational Gastroenterology 2026; doi: 10.14309/ctg.0000000000001059
|
| 2 |
Seong-Uk Baek, Jin-Ha Yoon. High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction. Biomolecules 2024; 14(11) doi: 10.3390/biom14111468
|
| 3 |
Xiaoyan Chen, Luanluan Huang, Ruiqi Liu, Ding Nan, Yucheng Li, Weijun Chen, Lei Shi, Ying Wang, Xiaodong Liang, Jianming Tang, Haibo Zhang, Yanwei Lu. Cuproptosis as a regulator in human diseases: From basic mechanisms to clinical relevance. International Immunopharmacology 2026; 168 doi: 10.1016/j.intimp.2025.115788
|
| 4 |
Alfredo Smiriglia, Nicla Lorito, Marina Bacci, Angela Subbiani, Francesca Bonechi, Giuseppina Comito, Marta Anna Kowalik, Andrea Perra, Andrea Morandi. Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease. Cell Death & Disease 2025; 16(1) doi: 10.1038/s41419-025-07331-7
|
| 5 |
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus. Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review. Biomedicines 2022; 11(1) doi: 10.3390/biomedicines11010106
|
| 6 |
Xiulu Guan, Shiyuan Shen, Jinxia Liu, Hongru Song, Jinhua Chang, Xiaoxia Mao, Jingyu Song, Lin Zhang, Cuizhe Liu. Protective effects of baicalin magnesium on non-alcoholic steatohepatitis rats are based on inhibiting NLRP3/Caspase-1/IL-1β signaling pathway. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-03903-2
|
| 7 |
Xueqing Wang, Teresa Pont, Jordi Rello. Sex- and Age-Related Differences Among Liver Transplant Patients: A Narrative Review. Journal of Intensive Care Medicine 2026; doi: 10.1177/08850666261447863
|
| 8 |
Peikai Zhao, Juanjuan Zou, Yuxuan Li, Shaozhuang Liu, Ze-Hua Zhao, Xin Huang. Obstructive sleep apnea mediates the association between body mass index and metabolic dysfunction-associated steatotic liver disease in patients with obesity. Hepatology International 2026; doi: 10.1007/s12072-026-11101-8
|
| 9 |
Yanfang Li, Bo Feng, Jingjing Cai. Effects of Mobile Health Technology Interventions on Body Weight and Liver Enzymes in Patients With Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 2026; 60(2) doi: 10.1097/MCG.0000000000002295
|
| 10 |
Kasimu Ghandi Ibrahim, Eliton Chivandi, Kennedy Honey Erlwanger, Richard Leslie Brooksbank. Neonatal administration of fenofibrate had no developmental programming effect on the lipid profile and relative leucocyte telomere lengths of adolescent rats fed a high-fructose diet postnatally. Canadian Journal of Physiology and Pharmacology 2023; 101(11) doi: 10.1139/cjpp-2022-0528
|
| 11 |
Multi-omics investigations reveal the critical role of the liver-microbiota-gut axis in tetrabromobisphenol S-induced liver fibrosis. Ecotoxicology and Environmental Safety 2026; 318 doi: 10.1016/j.ecoenv.2026.120215
|
| 12 |
Yan Gong, Juan Kang, Xinyan Wang, Yansong Zheng, Ying Sui, Wenping Lu. Increased detection rates of advanced colorectal adenoma in women with metabolic dysfunction-associated fatty liver disease. Heliyon 2023; 9(11) doi: 10.1016/j.heliyon.2023.e22391
|
| 13 |
Lucy C. Taylor, Gertrude Arthur, Marcella de Carvalho Cruz, David E. Stec, Olufunto O. Badmus. Contribution of Sex Differences to Development of Cardiovascular Disease in Metabolic-Associated Steatotic Liver Disease (MASLD). International Journal of Translational Medicine 2024; 4(4) doi: 10.3390/ijtm4040052
|
| 14 |
Ilaria Milani, Marianna Chinucci, Frida Leonetti, Danila Capoccia. MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women. Biomedicines 2025; 13(4) doi: 10.3390/biomedicines13040855
|
| 15 |
Bingxin Huangfu, Teng Wang, Dongbao Cai, Jia Xu, Kunlun Huang, Zhihong Liang, Weibin Bai, Xiaoyun He. Cyanidin-3-glucoside mitigates zearalenone-enhanced hepatic lipotoxicity via inhibition of PXR activation. Food Research International 2026; 240 doi: 10.1016/j.foodres.2026.119687
|
| 16 |
Chong Hu, Ziqi Yu, Changli Wei, Guotai Sheng, Jianyong Chen, Yang Zou. Evaluating the relative importance of different blood pressure indices in screening for NAFLD: a survey report based on a health examination population. Frontiers in Cardiovascular Medicine 2024; 11 doi: 10.3389/fcvm.2024.1338156
|
| 17 |
Sofia Tamini, Adele Bondesan, Diana Caroli, Nicoletta Marazzi, Alessandro Sartorio. The Ability of the Triglyceride-Glucose (TyG) Index and Modified TyG Indexes to Predict the Presence of Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome in a Pediatric Population with Obesity. Journal of Clinical Medicine 2025; 14(7) doi: 10.3390/jcm14072341
|
| 18 |
Ravi Sonkar, Hong Ma, David J Waxman. Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progression. Toxicological Sciences 2024; 200(2) doi: 10.1093/toxsci/kfae057
|
| 19 |
Álvaro Pejenaute Martínez de Lizarrondo, Paula Martín-Climent, María Martínez-Rubio, Jesús Saborido-Gavilán, Neira Sáinz, Elisa Félix-Soriano, Miriam Samblas, Mónica Alfonso-Núñez, Elizabeth Guruceaga, M. Pilar Lostao, Pedro González-Muniesa, María J. Moreno-Aliaga. Transcriptomic Changes Underlying the Anti-Steatotic Effects of DHA Supplementation in Aged Obese Female Mice. International Journal of Molecular Sciences 2025; 26(23) doi: 10.3390/ijms262311689
|
| 20 |
Tengrui Cao, Chao Tong, Qiang Li, Yumei Han, Aheyeerke Halengbieke, Xuetong Ni, Bo Gao, Deqiang Zheng, Xinghua Yang. Association of sex-specific body mass index and waist circumference trajectories with non-alcoholic fatty liver disease incidence based on growth mixture modeling. Nutrition, Metabolism and Cardiovascular Diseases 2024; 34(5) doi: 10.1016/j.numecd.2024.01.001
|
| 21 |
Sara Alqudah, Beckey DeLucia, Lucas J. Osborn, Rachel L. Markley, Viharika Bobba, Sarah M. Preston, Tharika Thambidurai, Layan Hamidi Nia, Clifton G. Fulmer, Naseer Sangwan, Ina Nemet, Jan Claesen. The diet-derived gut microbial metabolite 3-phenylpropionic acid reverses insulin resistance and obesity-associated metabolic dysfunction. Molecular Metabolism 2025; 102 doi: 10.1016/j.molmet.2025.102272
|
| 22 |
Andrea G. Izquierdo, Marcos C. Carreira, Gemma Rodriguez-Carnero, Raquel Perez-Lois, Luisa M. Seoane, Felipe F. Casanueva, Ana B. Crujeiras. Gender Dimorphism in Hepatic Carcinogenesis-Related Gene Expression Associated with Obesity as a Low-Grade Chronic Inflammatory Disease. International Journal of Molecular Sciences 2022; 23(23) doi: 10.3390/ijms232315002
|
| 23 |
Yun Mao, Huilan Chen, Weihan Zhu, Shunlan Ni, Shengnan Luo, Shiyue Tang, Zhiyi Chen, Qin Wang, Jinxian Xu, Qi Tu, Haijun Chen, Lujian Zhu. Cuproptosis Cell Death Molecular Events and Pathways to Liver Disease. Journal of Inflammation Research 2025; doi: 10.2147/JIR.S498340
|
| 24 |
María Fernanda Castillo, Daniela Salgado-Canales, Marco Arrese, Francisco Barrera, Dimitri P Mikhailidis. Effect of Intermittent Fasting on Lipid Profile, Anthropometric and
Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A
Systematic Review. Current Vascular Pharmacology 2024; 22(3) doi: 10.2174/0115701611285401240110074530
|
| 25 |
Linda L Wong, Akane Nogimura, Muaataz Azawi, Josh Warner, Tomoki Sempokuya. Current status of disparity in liver disease. World Journal of Hepatology 2022; 14(11): 1940-1952 doi: 10.4254/wjh.v14.i11.1940
|
| 26 |
Lucia De la Cruz-Color, Jose Alfredo Dominguez-Rosales, Montserrat Maldonado-González, Bertha Ruíz-Madrigal, Martha P. Sánchez Muñoz, Vianney Alejandrina Zaragoza-Guerra, Victor H. Espinoza-Padilla, Elizabeth del C. Ruelas-Cinco, Sandra M. Ramírez-Meza, José R. Torres Baranda, María del R. González-Gutiérrez, Zamira Helena Hernandez Nazara. Evidence That Peripheral Leptin Resistance in Omental Adipose Tissue and Liver Correlates with MASLD in Humans. International Journal of Molecular Sciences 2024; 25(12) doi: 10.3390/ijms25126420
|
| 27 |
Anna Marsal-Beltran, Adrià Rodríguez-Castellano, Brenno Astiarraga, Enrique Calvo, Patricia Rada, Ana Madeira, M-Mar Rodríguez-Peña, Gemma Llauradó, Catalina Núñez-Roa, Beatriz Gómez-Santos, Elsa Maymó-Masip, Ramon Bosch, María Dolores Frutos, José María Moreno-Navarrete, Bruno Ramos-Molina, Patricia Aspichueta, Jorge Joven, José-Manuel Fernández-Real, Juan Carlos Quer, Ángela M. Valverde, Albert Pardo, Joan Vendrell, Victòria Ceperuelo-Mallafré, Sonia Fernández-Veledo. Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD. Metabolism 2023; 145 doi: 10.1016/j.metabol.2023.155630
|
| 28 |
Mohamad Jamalinia, Amedeo Lonardo, Ralf Weiskirchen. Sex and Gender Differences in Liver Fibrosis: Pathomechanisms and Clinical Outcomes. Fibrosis 2024; 2(4) doi: 10.70322/fibrosis.2024.10006
|
| 29 |
Tomoko Kimura, Kodai Hino, Minoru Kuroida, Jun Udagawa. Early prenatal undernutrition leads to metabolic dysfunction-associated steatotic liver disease in a rat model of menopause. Journal of Developmental Origins of Health and Disease 2025; 16 doi: 10.1017/S204017442510024X
|